According to the Zhitong Finance App, Shiyao Group (01093.HK) issued an announcement. Nidanib ethanesulfonate inhalation powder developed by the Group has been approved by the China National Drug Administration and can conduct clinical trials in China.

According to the Zhitong Finance App, Shiyao Group (01093.HK) issued an announcement. Nidanib ethanesulfonate inhalation powder developed by the Group has been approved by the China National Drug Administration and can conduct clinical trials in China.